Ivy Brain Tumor Center Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2018
NCT03834740
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chief Scientific Officer/Director of the Ivy Brain Tumor Center | Deputy Director of the Ivy Brain Tumor Center | Ivy Brain Tumor Center